Analyst Tejas Savant from Morgan Stanley maintained a Hold rating on Charles River Labs (CRL – Research Report) and decreased the price target to $184.00 from $220.00.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Tejas Savant’s rating is based on a combination of factors, primarily focusing on the updated financial forecasts and the valuation model applied. The preliminary guidance for 2025 provided by Charles River Labs has led to a revision in the revenue forecasts, which have been lowered for both 2025 and 2026, indicating potential challenges in achieving previous growth expectations.
Savant employed a discounted cash flow analysis with a weighted average cost of capital of 7.5% and a terminal growth rate of 2.0% to determine the price target of $184. This valuation, coupled with the current market conditions and updated revenue outlook, supports a Hold rating as it suggests the stock is fairly valued at its current market price of $161.62.
In another report released yesterday, Evercore ISI also maintained a Hold rating on the stock with a $195.00 price target.